Nestlé commences tender offer for Aimmune Therapeutics, Inc. |
September 14, 2020 | September 2020 Bond Updates |
VEVEY, Switzerland, Sept. 14, 2020 /PRNewswire/ -- Société des Produits Nestlé S.A. ("Nestlé") announced that its wholly-owned subsidiary, SPN Merger Sub, Inc. ("Purchaser"), is commencing today a cash tender offer to purchase all of the outstanding shares of common stock of Aimmune... |
View more at: https://www.prnewswire.com:443/news-releases/nestle-commences-tender-offer-for-aimmune-therapeutics-inc-301128549.html |
Related News |
|